Studies have shown that active fund managers routinely underperform the S&P500 index*​

Turn Therapeutics Inc. (NASDAQ: TTRX)

TTRX Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-33.60%

TTRX Stock Analysis

TTRX PE Ratio:

TTRX PEG Ratio: Not Available

TTRX Forward EPS Growth (12 month): 0.00%

TTRX PS Ratio:

TTRX PSG Ratio:

TTRX Forward Revenue Growth (12 month): -98.70%

TTRX Articles

No data was found